Among those with advanced gastric cancer, oral Liporaxel showed superior overall survival outcomes versus IV Liporaxel as a second-line therapy.

The clock has been reset for a Canadian who has been on death row in Montana for 42 years after state legislators defeated an ...

The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both intravenous and subcutaneous formulations, according to a press release.

In the report, the experts also hinted that the Ringer's Lactate (RL) on the Intravenous (IV) fluid allegedly administered ... administration of the Oxytocin injection to these patients," the ...

The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.

A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...

LOVELAND, CO, UNITED STATES, January 29, 2025 /EINPresswire / -- The newly opened Suite Health infusion clinic provides personalized infusion therapy options for clients seeking targeted infusion ...

The U.S. Food and Drug Administration (FDA) has approved Celltrion’s AVTOZMA (CT-P47, tocilizumab-anoh) in both an intravenous (IV) and subcutaneous (SC) formulation as a biosimilar to ACTEMRA.

Oral paclitaxel matched IV in progression-free survival but outperformed it in overall survival for second-line advanced gastric cancer.

Intravenous (IV): when a needle is inserted into a vein to administer ... Notably, the press release notes that Enable Injections’ enFuse hands-free OBDS was used in the IRAKLIA study, which was ...

Patients would have to start with biweekly IV infusions and then would have the option ... Lilly is testing both subcutaneous injections and intravenous infusions, according to a company spokesperson.